HOME >> BIOLOGY >> NEWS
Breaking the rules on artifical blood

Numerous past attempts to develop synthetic blood have failed because doctors got the basic science wrong, claim a handful of researchers.

This week it was announced that a blood substitute based on their alternative theories is looking promising in an early trial. Developing a suitable blood substitute for people has been a major effort for decades. An artificial blood would relieve shortages and prevent patients being infected by contaminated supplies.

Ideally, it could be given to anyone without triggering rejection, so accident victims could be given transfusions immediately without testing to see what blood group they are. And a long-lasting form that does not need to be kept cold would be ideal for use in disasters, wars and remote areas. But company after company has worked on substitutes only to abandon their efforts because of safety concerns.

Most blood substitutes are based on various forms of haemoglobin, the protein that carries oxygen in most animals. The guiding principles are that artificial blood should be thinner than real blood, so that it circulates easily, and have a low affinity for oxygen, so that it releases oxygen easily.

In the past decade, initial trials of several substitutes looked promising. But it turned out many had a disastrous effect- they made capillaries collapse, shutting off the oxygen supply to tissues.

The reason, most researchers think, is that the haemoglobin in artificial bloods is free-floating, instead of being enclosed in red blood cells.

This allows it to enter the spaces between cells, where it mops up nitric oxide- a molecule that helps keep blood vessels open. But Marcos Intaglietta of the University of California, San Diego, is one of a small number of scientists who think the physical characteristics of blood substitutes are to blame.

He argues that they thin the blood, reducing shear stress in the capillaries and leading to vasoconstriction. Creating a
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
10-Mar-2004


Page: 1 2 3

Related biology news :

1. Breaking new ground in germ cell guidance
2. Breaking the silence: Discovery could lead to new treatments for cancer, sickle-cell anemia
3. Breaking into the brain
4. Ground-Breaking DNA Research Leads SFU Grad To The Top
5. Tests show biotech corn rules need revision
6. Scientists say new mercury rules could mean continued risk for loons
7. Kiss-and-run rules the inner lives of neurons
8. Simple rules predict the outcome of predator-prey struggles
9. Study indicates certain rules underlie calling behavior of bullfrogs
10. UC Davis research helps state air board set auto-emission rules
11. Food web theory suggests ecology may be governed by general rules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the ... clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief ... clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an ...
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal Purchasing System (TIPS), ... membership, recently named BioFit Engineered Products an Awarded Vendor. Awarded Vendor ... seating, cafeteria tables, book trucks and carts at discounted pricing without the delay ...
(Date:6/28/2020)... Conn. (PRWEB) , ... June 25, 2020 , ... ... formed to advance photodynamic therapy for treating cancer, today announced the company has ... York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell ...
Breaking Biology Technology:
Cached News: